Compositions and Production of Recombinant AAV Viral Vectors Capable of Glycoengineering In Vivo

摘要

The disclosure provides an expression vector (e.g., AAV vector) comprising a nucleic acid sequence encoding (1) the heavy and/or light chain of an antibody and (2) one or more shRNA sequences targeting fucosyltransferase-8 (FUT8).